<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08588006940282</udiDi>
    <basicUdiDi>08588006940TD004XK</basicUdiDi>
    <tradeName>Ocusan Single-Dose Eye Drops</tradeName>
    <deviceName>Ocusan</deviceName>
    <manufacturerName>Agepha Pharma</manufacturerName>
    <manufacturerSrn>SK-MF-000018617</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08588006940282</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-07-16T03:46:17.278Z</lastUpdated>
  </row>
  <row>
    <udiDi>08588006940251</udiDi>
    <basicUdiDi>08588006940TD002XF</basicUdiDi>
    <tradeName>Siccaforte Eye Gel</tradeName>
    <deviceName>Siccaforte Eye Gel</deviceName>
    <manufacturerName>Agepha Pharma</manufacturerName>
    <manufacturerSrn>SK-MF-000018617</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08588006940251</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-07-16T03:46:12.479Z</lastUpdated>
  </row>
  <row>
    <udiDi>08588006940244</udiDi>
    <basicUdiDi>08588006940TD003XH</basicUdiDi>
    <tradeName>Siccasan Eye Gel</tradeName>
    <deviceName>Siccasan Eye Gel</deviceName>
    <manufacturerName>Agepha Pharma</manufacturerName>
    <manufacturerSrn>SK-MF-000018617</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>08588006940244</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-07-16T03:46:11.679Z</lastUpdated>
  </row>
  <row>
    <udiDi>09003585000275</udiDi>
    <basicUdiDi>B-09003585000275</basicUdiDi>
    <tradeName>iGel Eye Drops</tradeName>
    <deviceName>iGel Eye Drops</deviceName>
    <manufacturerName>Agepha Pharma</manufacturerName>
    <manufacturerSrn>SK-MF-000018617</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q02030299</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, LIQUID FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>09003585000275</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-07-10T19:30:00.753Z</lastUpdated>
  </row>
</eudamedExport>